PVR and cervical carcinoma: For immunostimulator, SLC30A1 expression positively correlated with IL6R (Spearman: ρ = 0.204, P = 0.000345), TNFSF15 (Spearman: ρ = 0.355, P = 2.19e-10), NT5E (Spearman: ρ = 0.299, P = 1.16e-07), and PVR (Spearman: ρ = 0.236, P = 3.29e-05) in cervical carcinoma (Figure 7C-7D).